The annual joint scientific meeting of the Singapore Radiological Society and the College of Radiologists, Singapore, was expanded this year to include the Singapore General Hospital nuclear medicine update. This allowed a greater inclusion of topics pertaining to nuclear medicine and radiation oncology, with the theme of the meeting being “imaging and therapy in the area of molecular medicine.”
The annual joint scientific meeting of the Singapore Radiological Society and the College of Radiologists, Singapore, was expanded this year to include the Singapore General Hospital nuclear medicine update. This allowed a greater inclusion of topics pertaining to nuclear medicine and radiation oncology, with the theme of the meeting being “imaging and therapy in the area of molecular medicine.”
Dr Ajit K Padhy, chair of the organizing committee, has had extensive experience in the organization of scientific conferences. He was ably supported by scientific cochairpersons and committee members from the disciplines of diagnostic radiology, radiation oncology, and nuclear medicine in Singapore.
Together, they were able to invite renowned faculty to speak and share at the conference, including 19 overseas speakers from both the Association of Southeast Asian Nations (ASEAN) region as well as from the U.K., Canada, Australia, Germany, Austria, India, Kuwait, China, and the U.S. The F.Y. Khoo Memorial lecture was delivered by Prof Richard Baum (Germany), on the topic of “Ectropy and entropy-how molecules talking to each other create the fascination of molecular imaging.”
The meeting was held at the conference facilities of the Holiday Inn Atrium, Singapore, from Feb. 25 to 28, 2010. It attracted more than 400 participants, with a significant proportion coming from the region around Singapore, and also including many radiographers and nuclear medicine and radiation oncology technologists.
The program was tailored to cater for all three disciplines, with each of the sessions centered on a particular disease or pathology, such as lung cancer, hepatic malignancies, GI imaging, and so on. This allowed cross-sharing and exposure of imaging and treatment options between the speakers and participants from the different areas. This feature was a particular high point for many, who benefited from the multidisciplinary approach to the lectures. A detailed program and speaker list can be found here.
All in all, it was an excellent meeting to bring the diagnostic and therapeutic imaging community in Singapore together, to learn both from and about each other’s work, as well as to make and renew social ties with friends and colleagues from Singapore and abroad.
Dr. Tsou is vice chair of the Chapter of Diagnostic Radiologists Committee of the College of Radiologists, Singapore.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.